Explore the detailed record of transactions filed by Urist Marshall, Vice-Président Exécutif et Co-Responsable de la Recherche et des Investissements. Insider active across 1 companies, notably Royalty Pharma plc. Cumulatively, 13 reports have been published. Total volume traded: €5.4m. The latest transaction was filed on 14 May 2026 — Cession. Regulator: SEC (Form 4). All data is openly available.
Marshall Urist is the Executive Vice President and Co-Head of Research and Investments at Royalty Pharma plc. He oversees the company's research and investment initiatives.